Ina Research Inc
TSE:2176
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Ina Research Inc
Operating Expenses
Ina Research Inc
Operating Expenses Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
I
|
Ina Research Inc
TSE:2176
|
Operating Expenses
-¥691.2m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
0%
|
|
|
Carna Biosciences Inc
TSE:4572
|
Operating Expenses
-¥2.5B
|
CAGR 3-Years
0%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-12%
|
|
|
S
|
Shin Nippon Biomedical Laboratories Ltd
TSE:2395
|
Operating Expenses
-¥14.1B
|
CAGR 3-Years
-28%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
-8%
|
|
|
Medinet Co Ltd
TSE:2370
|
Operating Expenses
-¥1.6B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
4%
|
|
|
CellSource Co Ltd
TSE:4880
|
Operating Expenses
-¥1.8B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
N/A
|
|
|
Immuno-Biological Laboratories Co Ltd
TSE:4570
|
Operating Expenses
-¥417.7m
|
CAGR 3-Years
3%
|
CAGR 5-Years
12%
|
CAGR 10-Years
3%
|
|
Ina Research Inc
Glance View
Ina Research, Inc. engages in the development of pharmaceutical products. The company is headquartered in Ina-Shi, Nagano-Ken and currently employs 194 full-time employees. The company went IPO on 2008-06-25. The firm operates in two business segments. The Contract Test segment is engaged in the provision of non-clinical test services to confirm the safety and efficacy of developed pharmaceuticals and food materials based on laboratory animals and cells for pharmaceutical development companies, food-related companies, research institutes and others. The Environmental segment is engaged in the design and sale of animal facilities for pharmaceutical companies and universities, deodorant-loaded devices, sterilization equipment, equipment for laboratory animals and others.
See Also
What is Ina Research Inc's Operating Expenses?
Operating Expenses
-691.2m
JPY
Based on the financial report for Mar 31, 2022, Ina Research Inc's Operating Expenses amounts to -691.2m JPY.
What is Ina Research Inc's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
0%
Over the last year, the Operating Expenses growth was 2%. The average annual Operating Expenses growth rates for Ina Research Inc have been -7% over the past three years , -6% over the past five years .
